ARYZTA (ARYN) Q4 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 TU earnings summary
22 Jan, 2026Executive summary
Achieved or exceeded FY2025 guidance with organic growth in the low to mid-single-digit range, supported by both volume and price improvements, despite a subdued consumer environment.
EBITDA exceeded €305 million, with free cash flow between €115 million and €120 million.
Financing costs, including lease interest, were significantly below guidance at €42–44 million.
Key customer negotiations completed, providing good visibility on pricing for 2026 and supporting profitable growth.
Management implemented structural changes and cost reductions to accelerate revenue growth and improve performance for 2026.
Financial highlights
Organic growth for FY2025 confirmed in the low to mid-single-digit range.
EBITDA above €305 million; free cash flow in the €115–120 million range.
Financing costs, including lease interest, at €42–44 million, below previous guidance.
CapEx for 2025 at levels comparable to 2024.
Net debt, including all items, expected to be below €800 million for 2025.
Outlook and guidance
Expects further positive organic growth and improved business performance in 2026, driven by new production lines and successful customer negotiations.
Free cash flow conversion of EBITDA targeted above 40% over the midterm plan.
CapEx for 2026 and 2027 to remain within 3.5–4.5% of revenue, with Portugal investment spread over both years.
Focus remains on performance improvement, cash generation, and capital return to shareholders as per 2025–2028 mid-term plan.
Further details on guidance to be provided on March 2nd.
Latest events from ARYZTA
- Revenue, EBITDA, and cash flow rose; capital return policy and bond repurchase set for 2026.ARYN
Q4 20252 Mar 2026 - EBITDA margin rose to 14.2% on €1,055.2m revenue, with leverage down to 2.9x.ARYN
H1 20241 Feb 2026 - EBITDA guidance reset to €300m for 2025; interim CEO appointed to drive improvements.ARYN
Investor Update14 Dec 2025 - Midterm targets met early, with higher margins, strong cash flow, and double-digit EPS growth.ARYN
H2 202410 Dec 2025 - Revenue and EPS rose, with margin pressured by inflation but guidance reaffirmed.ARYN
H1 202523 Nov 2025 - Targets above-market growth and >15% EBITDA margin by 2028 through innovation and efficiency.ARYN
CMD 202517 Nov 2025 - Q3 organic growth 0.8%, YTD 2.1%, FY25: €300m EBITDA, €100m free cash flow, cost optimisation.ARYN
Q3 2025 TU20 Oct 2025 - Innovation-led growth, margin expansion, and strong cash flow drive ARYZTA's robust performance.ARYN
Investor Presentation13 Jun 2025 - Q3 organic growth rebounded to 2.0%, with strong volumes and cost-saving initiatives underway.ARYN
Q3 2024 TU13 Jun 2025